Passage BIO, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Passage BIO, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Passage BIO, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $1.25M, a 20.6% decline year-over-year.
  • Passage BIO, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $5.82M, a 46.7% decline year-over-year.
  • Passage BIO, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $5.82M, a 46.7% decline from 2023.
  • Passage BIO, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.9M, a 42.4% decline from 2022.
  • Passage BIO, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $19M, a 42% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.82M -$5.1M -46.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 $10.9M -$8.03M -42.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 $19M -$13.7M -42% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-04
2021 $32.7M +$18.1M +124% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $14.6M +$13.1M +903% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $1.45M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.